Why the study?
Does early post-thrombolysis coronary stenting provide safety and prevent reocclusion in patients with acute myocardial infarction?
Does early post-thrombolysis coronary stenting provide safety and prevent reocclusion in patients with acute myocardial infarction?
Early coronary stenting after thrombolysis for acute myocardial infarction is safe and feasible, demonstrating a very low 1% reocclusion rate at 6 months.
Supports safety of early post-thrombolysis stenting in AMI; leaves open efficacy confirmation in randomized trials.
To determine the feasibility and safety of early posthrombolysis coronary stenting and the incidence of further reocclusion, we followed 99 consecutive patients with acute myocardial infarction thrombolyzed with rt-PA 2.0 +/- 0.8 hr after onset. Culprit artery was stented 14.0 +/- 7.0 hr after thrombolysis. All patients underwent clinical and angiographic follow-up at 1 and 6 months. Angiographic success was achieved in 99% of cases. Neither major cardiac events nor bleeding or vascular complications occurred during hospital stay. At 30 days, no events occurred and normal flow persisted in all stented arteries. At 6 months, only one artery reoccluded (1%), resulting in a nonfatal reinfarction. Restenosis rate was 21%. Contribution of the infarcted area to left ventricular function significantly increased from baseline to 30-day and to 6-month evaluations. Thus, early posthrombolysis stenting is a safe strategy with a low reocclusion rate, which seems to allow functional recovery of the infarcted area. Further studies are necessary to define its impact on survival and cost-effectiveness.
No takes yet. Share an insight, caveat, or question.
Fernández‐Avilés et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: